UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053007
Receipt number R000060468
Scientific Title Clinicopathological features of locally recurrent rectal cancer in Japan: a nationwide cohort database
Date of disclosure of the study information 2023/12/05
Last modified on 2023/12/05 19:24:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinicopathological features of locally recurrent rectal cancer in Japan: a nationwide cohort database

Acronym

Clinicopathological features of locally recurrent rectal cancer in Japan: a nationwide cohort database

Scientific Title

Clinicopathological features of locally recurrent rectal cancer in Japan: a nationwide cohort database

Scientific Title:Acronym

Clinicopathological features of locally recurrent rectal cancer in Japan: a nationwide cohort database

Region

Japan


Condition

Condition

locally recurrent rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the clinicopathological features and outcomes of locally recurrent rectal cancer in Japan from a nationwide cohort database.

Basic objectives2

Others

Basic objectives -Others

To identify the impact of imaging findings and pathologic factors on the outcome of locally recurrent rectal cancer.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To clarify the long-term outcomes of the patients with locally recurrent rectal cancer by treatment modality.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with a clinical or pathological diagnosis of locally recurrent rectal cancer between January 1, 2011 and July 31, 2023.
2. Local recurrence after R0/1 excision.
3.Previous radiotherapy or chemotherapy for rectal cancer, distant metastasis, or resection of metastases are not included.

Key exclusion criteria

1. Patients who refuse to participate in this study

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Kay
Middle name
Last name Uehara

Organization

Nippon Medical School

Division name

GI and HBP Surgery

Zip code

113-8603

Address

Sendagi 1-1-5, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Email

kueharam123185m@yahoo.co.jp


Public contact

Name of contact person

1st name Masanori
Middle name
Last name Sando

Organization

Nagoya Ekisaikai Hospital

Division name

Surgery

Zip code

454-8502

Address

Shonen-cho 4-66, Nakagawa-ku, Nagoya city

TEL

052-652-7711

Homepage URL


Email

masanori.sando@hotmail.com


Sponsor or person

Institute

Japanese Society for Cancer of the Colon and Rectum

Institute

Department

Personal name



Funding Source

Organization

Japanese Society for Cancer of the Colon and Rectum

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School Ethical Committee

Address

Sendagi 1-1-5, Bunkyo-ku, Tokyo

Tel

03-3822-2131

Email

nms_fuzokurinri@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 10 Month 24 Day

Date of IRB

2023 Year 10 Month 24 Day

Anticipated trial start date

2023 Year 11 Month 20 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A multi-center retrospective study


Management information

Registered date

2023 Year 12 Month 05 Day

Last modified on

2023 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060468